Fanconi Anemia

This is a rare genetic condition that affects the body's blood-forming tissues. It causes the bone marrow to not produce enough healthy blood cells, leading to anemia (low red blood cells), low white blood cells, and low platelets. People with Fanconi Anemia also have an increased risk of developing certain cancers, like leukemia. It's caused by changes in specific genes.

Condition

What people with Fanconi Anemia report

Every report comes from a Lived member, sent anonymously.

Have you had Stem Cell Transplant for Fanconi Anemia?

NameHow it went

About Fanconi Anemia

What It Is

Fanconi anemia (FA) is a rare inherited condition in which the body cannot properly repair a particular kind of DNA damage. It has three main effects: bone marrow failure, physical differences that are often present from birth, and a much higher than usual risk of certain cancers. Despite the similar name, it is unrelated to Fanconi syndrome, a kidney disorder. Bone marrow is the spongy tissue inside bones that makes red blood cells (which carry oxygen), white blood cells (which fight infection) and platelets (which help blood clot). In most people with FA, the marrow gradually makes fewer of all three. That can show up as tiredness and pale skin from anemia, repeated infections from low white cell counts, and easy bruising or nosebleeds from low platelets. Blood count problems often appear in childhood, frequently between ages 6 and 8, but the timing varies widely, even between siblings. More than half of children with FA are born with at least one physical difference, such as short stature, missing or unusually shaped thumbs or forearm bones, patches of darker or lighter skin, a small head or small eyes, or malformations of the kidneys or heart. Others have none, which is one reason FA is sometimes recognized late, occasionally not until adulthood. Hormone problems, including low thyroid levels, diabetes, delayed puberty and reduced fertility, are also common.

Causes & Risk Factors

FA is caused by inherited changes (variants) in one of more than 20 genes. The proteins these genes make work together as a repair system that fixes DNA when its two strands become abnormally linked. When the system fails, damage builds up in dividing cells. Some of those cells die, which contributes to marrow failure and to differences in development, while others grow out of control, which is how leukemia and other cancers arise. In most families, FA follows an autosomal recessive pattern: each parent carries one altered copy of the same gene and is usually healthy. When both parents are carriers, each pregnancy has a 25 percent chance of a child with FA, a 50 percent chance of a child who is a carrier, and a 25 percent chance of a child with neither. Rarely, FA is X-linked, passed through a carrier mother and affecting mostly boys, or results from a new gene change in the child. FA affects roughly 1 in 100,000 to 160,000 people worldwide. It is more common in some groups, including people of Ashkenazi Jewish descent, the Roma population of Spain and the Afrikaner population of South Africa, and a family history of FA raises the chance in brothers and sisters.

How It's Diagnosed

Doctors consider FA in a child born with typical physical differences, in anyone of any age who develops aplastic anemia (failure of the marrow to make enough of all blood cells), in the brothers and sisters of someone with FA, and in young adults who develop squamous cell cancer of the mouth, throat or genital area at an unusually early age. Unusually severe side effects from chemotherapy can also be a clue. The key test is a chromosome breakage test. In the lab, blood cells are exposed to a chemical that links DNA strands together (diepoxybutane (DEB) or mitomycin C (MMC)). Normal cells repair most of this damage, while cells from someone with FA show many broken chromosomes. The test should be done at a laboratory experienced with FA. If the blood result is negative or unclear but suspicion remains, it can be repeated on skin cells. A positive result is followed by genetic testing to identify the gene variants involved, which allows relatives to be tested and informs family planning. Testing can also be done during pregnancy. All full siblings of a person with FA should be tested, even if they seem healthy, both to find FA early and to learn whether they could be a matched stem cell donor. After diagnosis, a baseline workup maps how FA affects that person: blood counts, a bone marrow exam, a kidney ultrasound, hearing and hormone tests, and tissue typing in case a transplant is needed later. Confirming or ruling out FA matters before any transplant or cancer treatment, because standard doses of chemotherapy and radiation can be dangerously toxic for people with FA.

Treatment Options

Care for FA is organized around the blood, cancer prevention and the other organs involved, usually led by a hematologist (blood specialist) with FA experience and coordinated with other specialists. Treatment can control or cure the marrow failure, but no current treatment removes the underlying DNA repair problem from the rest of the body. A hematopoietic stem cell transplant, often called a bone marrow transplant, replaces the person's blood-forming cells with a donor's. It is the only treatment that can cure the marrow failure and prevent progression to myelodysplastic syndrome (MDS, in which blood cells fail to mature normally) or acute myeloid leukemia (AML). Results are best when it is done in childhood, before leukemia or other cancers develop and before many transfusions; transplant in adults carries considerably higher risk. People with FA need gentler preparation regimens, with reduced chemotherapy and often no radiation. A transplant fixes the blood but not FA elsewhere: the risk of mouth, throat and genital cancers continues and can rise further after graft-versus-host disease (a complication in which donor immune cells attack the recipient's tissues). Because a transplant can also affect fertility, options are worth discussing beforehand. For people who are not ready for, or cannot have, a transplant, other treatments support blood counts. Androgens (man-made male hormones) raise counts in about half of people, most reliably red cells within a month or two, though the benefit can fade. They can cause masculinizing effects and liver problems, including liver tumors with long use, so liver blood tests and ultrasounds are part of treatment. Granulocyte colony-stimulating factor (G-CSF), an injected growth factor, can raise infection-fighting white cells, usually during an illness. Red cell and platelet transfusions are given when counts are dangerously low; they are limited when possible before a transplant, repeated transfusions can lead to iron buildup, and blood products for people with FA should be irradiated and cytomegalovirus (CMV) negative. Gene therapy, in which a person's own stem cells are corrected and returned, is being studied in clinical trials for the most common subtype, caused by the FANCA gene. Early results have been encouraging, but it is not yet standard care. Surgery can improve hand and arm function, and specialists manage hormone, hearing, kidney and digestive problems as they arise.

What to Expect

The course of FA varies a great deal. Some people have mildly low blood counts for years, while others develop severe marrow failure in childhood. Outlook has improved with earlier transplant, better supportive care and cancer screening, and about 80 percent of people with FA now live beyond age 18. For adults, the main long-term threat is cancer, especially squamous cell cancers of the head and neck and, in women, of the cervix, vulva and anal area. These tend to appear between ages 20 and 50, decades earlier than usual, whether or not a transplant was done. Living with FA means regular monitoring rather than occasional visits. Blood counts are checked every few months, and people who have not had a transplant usually have a bone marrow exam each year to catch early changes toward MDS or leukemia. From about age 10, a specialist familiar with FA examines the mouth and throat every six months, alongside dental visits every six months. Women start yearly gynecologic exams in adolescence, with cervical screening once sexually active or by age 18. Growth, thyroid function, puberty and blood sugar are usually checked yearly. Because FA cells are unusually sensitive to radiation, X-rays are kept to what is truly needed. Everyday habits carry more weight than in most conditions. Care guidelines advise avoiding tobacco smoke, including secondhand smoke and vaping, keeping alcohol to a minimum and skipping alcohol-based mouthwash, using sun protection, and limiting contact with chemicals such as formaldehyde, herbicides and solvents like gasoline or paint thinner. Vaccination against human papillomavirus (HPV) is recommended from age 9 for both boys and girls, since HPV is linked to cervical, vaginal and vulvar cancers. Fertility is often reduced, and many women reach menopause early, which affects bone health and family planning. Because people with FA often see many specialists and take several medicines, keeping one hematologist informed of everything prescribed helps avoid harmful combinations. The workload on families can be heavy, and FA centers, genetic counselors and patient organizations can help, including with the move from pediatric to adult care.

When to Seek Help

Ask about testing for FA if a child has thumb or forearm differences or several typical birth differences, if anyone develops unexplained low blood counts or aplastic anemia, if a sibling has FA, or if a young adult develops squamous cell cancer of the head, neck or genital area. Contact the care team about frequent infections, growing tiredness, a new mouth sore or patch, or pain or difficulty swallowing, rather than waiting for the next scheduled exam. For someone with FA and low white cell counts, a fever of 100.5°F (38°C) or higher, chills or other signs of infection call for a call to the care team right away, since infections can become serious quickly. Bleeding that starts for no clear reason or is hard to stop needs immediate care: contact the care team or go to the emergency room.

Questions to Ask Your Doctor

  1. 1.Which gene is involved in our case, and what does that mean for cancer risk and for testing other family members?
  2. 2.When should we start planning for a stem cell transplant, and could any relatives be a matched donor?
  3. 3.What monitoring schedule do you recommend for blood counts, bone marrow exams and head, neck and gynecologic screening?
  4. 4.Which medicines, imaging tests or exposures should we avoid, and how should we tell other doctors about FA?
  5. 5.What options are there to protect fertility, and how will care move from pediatric to adult specialists?

Last reviewed • Oct 2026

Educational content, not medical advice.